The use of serological tests containing multiple immunodominant antigens rather than single antigens have the potential to improve the diagnostic performance in Cystic Echinococcoses (CE) as a complement tool to clear the inconclusive imaging data. Here, we comparatively evaluated the diagnostic value of Hydatid Fluid (HF) and the recently described recombinant multi-epitope antigen DIPOL in IgG-ELISA in a clinically defined cohort of CE patients. The serum samples from 149 CE patients were collected just before surgical or Percutaneous- Aspiration- Injection- Reaspiration (PAIR) procedures. Additionally, serum samples of patients with other parasitic infections (n=49) and healthy individuals (n=21) were also included in the study as controls. To investigate the association between the genotype of the parasite and DIPOL, cyst materials from 20 CE patients were sequenced. In terms of overall sensitivity, HF was higher than DIPOL (82.55%,78.52%, respectively). However, while the sensitivity of HF was higher than DIPOL in patients with active and transitional cysts (83.3%, 75.4%, respectively), sensitivity of DIPOL in inactive cysts was higher compared to HF (95.6%, 78.3%, respectively). The sensitivity of DIPOL depending on cyst stage was statistically significant (P= 0.041). In terms of specificity, DIPOL was found to be better than HF (97.71%, 91.43%, respectively). By genotyping, the majority of 20 patients showed G1 genotype (80%). All patients harboring G3 and G1/G3 cyst genotypes were positive with both antigens, while 87.5% of patients with G1 genotype were seropositive with HF and 75% with DIPOL. The overall sensitivity and high specificity of DIPOL suggest that this recombinant protein containing immunodominant epitopes is a potential substitute for the HF by serological tests for the diagnosis of CE.
Objective: Hepatocyte Growth Factor (HGF) is known to increase expression as in other cancer types. This study aimed to investigate expression at the transcriptional level of HGF expression. Because of this, we examined the presence of mutation in the hepatocellular carcinoma cells in the region of 30 reprocessed deoxyadenosine in the HGF promoter and found that it was related to high HGF levels Method: Two hepatocellular carcinoma cell lines and two human genomic DNA lines were used in this study. Genomic DNAs were obtained with the aid of kit and region specific primers were designed and amplified. Next, bi-directional Sequencing was done. Chromatogram data showed deoxy adenosine levels in the region. Subsequently, the present HGF expressions in these cells were compared with our data Results: When HGF mutations were normal in some hepatocellular carcinoma cells, shortening in DATE region was observed in nascent cell lines, and it was determined that the number of deoxyadenosine in the DATE region was normal in cells with high autocrine HGF expression Conclusion: HGF is responsible for the activation of autocrine HGF in the DATE region due to its transcription in some cancer types. Our results suggest that methylation levels should be examined in cell lines where the DATE region is normal and shortened in order to understand the role of HGF DATE region in expression
Evaluation of miR-146a Expression Levels in Archived Serum Samples for the Diagnosis/Follow-up of Patients with Cystic Echinococcosis - Turkish Journal of Parasitology